Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FULRX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,827
Award facts
- Contract value 100% obligated
- $83,827.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $83,827.01 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen auto-injectors on October 15, 2025, with completion scheduled for October 16, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, fulfills a critical role in the federal medical supply chain, providing pharmaceutical products and medical supplies to support military and veteran healthcare systems.
Dupixent (dupilumab) is a biologic medication indicated for treating moderate-to-severe atopic dermatitis, asthma, and other inflammatory conditions, and this delivery order supports the Department of Defense's ongoing pharmaceutical procurement needs through DLA's established prime vendor contracting vehicle. AmerisourceBergen's extensive federal contract portfolio demonstrates consistent capability to compete and perform under open competition across diverse pharmaceutical categories, ranging from specialty medications to vaccines and medical devices, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FULRX?
SPE2DB26FULRX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 15, 2025.
How much is contract SPE2DB26FULRX worth?
The government has obligated $83,827 on SPE2DB26FULRX.
Is contract SPE2DB26FULRX an order under another contract?
Yes. SPE2DB26FULRX is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB26FULRX competed?
The extent of competition for SPE2DB26FULRX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award